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Scopo del lavoro 
The trifecta is an accepted index of the excellent surgical outcome after partial nephrectomy. Aim of this 
study was to assess which clinical variables may be an independent predictors of the trifecta outcome in 
patients candidates to partial nephrectomy. 
 
Materiali e metodi 
The data of 440 patients treated with open partial nephrectomy for T1 RCC were reviewed in our multi-
center prospectively maintained database. Warm ischemia time (WIT)>25 min, complications, and 
postoperative acute kidney dysfunction (AKD), separately. The perioperative clinical variables associated 
with the Trifecta outcome, defined as warm ischemia time (WIT) 
 
Risultati 
The trifecta outcome was achieved in 315 (71.6%) patients; 7.5% of patients had WIT ≥ 25 min, 3.5% had 
PSM and 21.2% had perioperative complications. Reoperation rate for Clavien≥3 complication was 6.7%. 
On univariate analysis the trifecta was significantly associated with patients gender (p 
 
Discussione 
In our analysis the clarity of the surgical field, associated to the containment of intraoperative bleeding and 
a favorable tumor nephrometry, resulted of critical importance for the achievement of the excellent surgical 
outcome.  
 
Conclusioni 
I 
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NEPHRON SPARING SURGERY DOES NOT ALWAYS DECREASE OTHER-CAUSES 
MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH NORMAL 
PREOPERATIVE RENAL FUNCTION 
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Scopo del lavoro 
Some reports suggested that nephron sparing surgery (NSS) may better protect against other-cause mortality 
(OCM) when compared with radical nephrectomy (RN) in patients with small renal masses. However, 
the majority of those studies could not adjust their results for potential selection bias secondary to clinical 
baseline characteristics of patients. In the current study, we aimed to test the effect of treatment type (NSS 
vs. RN) after accounting for clinical characteristics, comorbidities and individual cardiovascular risk. 
 
Materiali e metodi 
A multi-institutional collaboration among four European Tertiary Care Centers allowed collecting 2685 
patients with a clinical T1a-T1b N0 M0 renal mass. Patients underwent RN (n=1059, 39.4%) or NSS 
(n=1626, 60.6%) and showed normal estimated glomerular filtration rates (eGFR) before surgery (defined as 
a pre-operative eGFR≥60 milliliters per minute per 1.73 m2). Descriptive, univariable and multivariable Cox 
regression analyses were used to predict the risk of OCM. To adjust for inherent baseline differences among 
patients, we included as covariates: age, clinical tumor size, gender, presence of hypertension at diagnosis, 
baseline Charlson comorbidity index (CCI), body mass index and smoker status.  
 
Risultati 
Mean follow up period was 76 months (median 61). Mean patient age resulted 60 years (median 62). Mean 
body mass index resulted 25 kg/m2. Overall, 37.2% and 9.4% of the patients had hypertension or diabetes, 
respectively. CCI resulted 0-1 in 73.2% of the patients. The 5- and 10-yr OCM rates after nephrectomy 
were 5.2% and 13.2% for NSS versus 7.4% and 15.1% for RN, respectively (p=0.3). At multivariable 
analyses, patients who underwent PN showed similar risk to die for OCM compared with their RN-treated 
counterparts (hazard ratio [HR]: 0.77; 95% confidence interval, 0.48-1.25; p=0.3). Increasing age (HR: 1.12, 
p 
 
Discussione 
Controversies exist whether nephron sparing surgery (NSS) may better protect against other-cause mortality 
(OCM) and renal function impairment (RFI) when compared with radical nephrectomy (RN) in the surgical 
treatment of patients with kidney cancer. Such uncertainty derives from the apparent contrast between the 
negative findings of the European Organization for Research and Treatment of Cancer (EORTC) randomized 
trial 30904 demonstrating no benefit in performing NSS and the majority of retrospective studies showing, 
conversely, an evident advantage in terms of overall survival and better postoperative renal function.  
 
Conclusioni 
After correcting for clinical characteristics, comorbidities and cardiovascular risk at diagnosis, NSS does not 
decrease other-causes mortality relative to RN in patients with clinical T1a-T1b renal masses and a normal 
kidney function before surgery.  
 
